Other · developed by LeonaBio
ATH-1020 is an oral capsule formulation.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT05169671 | Phase 1 | Healthy Volunteers | Completed | LONA |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Healthy Volunteers
Updated Oct 18, 2026. Something wrong or missing? Report it on the LONA page.
See LONA's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
LONA catalysts and pipeline →